# PATHOGENESIS OF VITAMIN D REFRACTORY DISEASES

> **NIH NIH R01** · DUKE UNIVERSITY · 1993 · $370,562

## Abstract

The vitamin D resistant disorders include a varied group of none
diseases refractory to treatment. At present, limited knowledge
regarding the pathophysiology of many such disorders precludes effective
therapy. X-linked hypophosphatemic rickets (XLH) is the prototypic
hypophosphatemic vitamin D resistant disease, characterized by renal
phosphate (Pi) wasting, aberrant regulation of vitamin D metabolism and
defective bone mineralization. Although these abnormalities are
representative of those exhibited by many of the hypophosphatemic
vitamin D resistant diseases, defective regulation of vitamin D
metabolism is a variable derangement. Indeed, similar variability is
exhibited by the murine homologues of the human diseases, the hyp- and
gy-mouse. Our proposed studies are designed to continue investigation of
the pathophysiological and genetic abnormalities underlying XLH and to
further improve the treatment for affected subjects. Studies in the
murine homologues will be employed to gain further insight to the
pathophysiological mechanism(s) operative in this disease. Employing
renal cross-transplantation we will explore of the abnormal renal Pi
transport in the various mutant mice is uniformly due to an
hormonal/Metabolic aberration (as documented in hyp-mice) or variably
due to an intrinsic derangement of renal tubular function. In addition,
we will use a variety of approaches to investigate the relationship
between abnormal renal Pi transport and aberrant regulation of
1,25(OH)2D production. In renal cross-transplantation studies of hyp-
mice, we will assess renal Pi transport and assay 25(OH)D-1- hydroxylase
in the resultant animal models to determine the linkage between these
abnormalities. In contrast, employing cultures of cells from the S1, S2,
and S3 segments of the proximal concolutes tubules from hyp- and gy-
mice, we will determine if occurrence of the Pi transport defect at
alternate loci or unique distribution of 25(OH)D-1-hydroxylase activity
underlies the variable occurrence of normal vitamin D metabolism in the
hypophosphatemic vitamin D resistant diseases. Studies in the hyp-mouse
will also include efforts to identify and characterize the humoral
factor apparently underlying the abnormal renal Pi transport in this
animal model. In these investigations we will assess the biological
characteristics of the Pi transport inhibitory activity present in serum
from hyp-mice and explore the liver as the potential organ that
synthesizes this humoral factor. Additionally, we will use standard
techniques to isolate the protein factor from the serum and perform
structural analysis. Efforts to elucidate the genetic abnormality in XLH
will be directed at localizing and eventually cloning the gene
responsible for this disease. These studies will include linkage
analysis, physical mapping of the Xp22.1 region ad ultimately fine
structure mapping techniques. Finally, evaluation of the therapeutic
strategy for XLH will place emphasis on determining if...

## Key facts

- **NIH application ID:** 3155495
- **Project number:** 5R01AR027032-14
- **Recipient organization:** DUKE UNIVERSITY
- **SAM.gov UEI:** TP7EK8DZV6N5
- **Principal Investigator:** MARC KENNETH DREZNER
- **Activity code:** R01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 1993
- **Award amount:** $370,562
- **Award type:** 5
- **Project period:** 1980-08-01 → 1996-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/3155495

## Citation

> US National Institutes of Health, RePORTER application 3155495, PATHOGENESIS OF VITAMIN D REFRACTORY DISEASES (5R01AR027032-14). Retrieved via MORVS 2026-10-24 from https://api.morvs.ai/grant/nih/3155495. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*
